Cargando…
Amyloid beta is an early responder cytokine and immunopeptide of the innate immune system
A molecular level conceptualization of the pathogenesis of Alzheimer's disease (AD) remains elusive with many competing hypotheses, particularly via proteopathic and immunopathic mechanisms. However, these need not be competitive. If amyloid beta (Aβ) is regarded as an “early responder cytokine...
Autor principal: | Weaver, Donald F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606184/ https://www.ncbi.nlm.nih.gov/pubmed/33163614 http://dx.doi.org/10.1002/trc2.12100 |
Ejemplares similares
-
Profound N-glycan remodelling accompanies MHC-II immunopeptide presentation
por: Goodson, Hayley, et al.
Publicado: (2023) -
MS(2)Rescore: Data-Driven Rescoring Dramatically Boosts Immunopeptide Identification Rates
por: Declercq, Arthur, et al.
Publicado: (2022) -
Finding chemopreventatives to reduce amyloid beta in yeast
por: Macreadie, Ian G., et al.
Publicado: (2016) -
Targeting amyloid precursor protein shuttling and processing - long before amyloid beta formation
por: Arbor, Sage
Publicado: (2017) -
Recent advancements toward non-invasive imaging of retinal amyloid-beta for early detection of Alzheimer’s disease
por: Wang, Liang, et al.
Publicado: (2022)